Condition

Hepatic Impairment

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 10 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials10
Recruiting0
Common interventions9
Lead sponsors shown10
Advertisement

Clinical trials

10 shown
A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic FunctionNCT06126575 · 2023-03-13
COMPLETED
Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls.NCT03813979 · 2020-11-15
WITHDRAWN
The Role and Dynamics of Liver Dysfunction in Patients Undergoing Cardiac SurgeryNCT02893657 · 2017-12-01
UNKNOWN
Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)NCT02115347 · 2014-09-19
COMPLETED
Pharmacokinetics of AGO178 in Participants With Liver ImpairmentNCT01531309 · 2011-02-08
COMPLETED
GSK1349572 Hepatic Impairment StudyNCT01231529 · 2010-11-19
COMPLETED
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy VolunteersNCT01146938 · 2010-05-01
COMPLETED
TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.NCT00736905 · 2008-06-01
COMPLETED
Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic ImpairmentNCT00162097 · 2004-11-01
COMPLETED
A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver FunctionNCT00791284 · 2004-08-01
COMPLETED

Trial status mix

COMPLETED8
UNKNOWN1
WITHDRAWN1

Phase mix

PHASE18
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.